Alzheimers Dement

1. TESI N, van der Lee S, Hulsman M, van Schoor NM, et al
   Cognitively healthy centenarians are genetically protected against Alzheimer's disease.
   Alzheimers Dement. 2024 Apr 18. doi: 10.1002/alz.13810.
   

   >> Share

   
   
2. MOLINA-HENRY DP, Raman R, Liu A, Langford O, et al
   Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial.
   Alzheimers Dement. 2024 Apr 17. doi: 10.1002/alz.13803.
   

   >> Share

   
   
3. LOPEZ DC, White ZJ, Hall SE
   Anxiety in Alzheimer's disease rats is independent of memory and impacted by genotype, age, sex, and exercise.
   Alzheimers Dement. 2024 Apr 16. doi: 10.1002/alz.13813.
   

   >> Share

   
   

   
   Ann Neurol

4. SAKOWSKI SA, Koubek EJ, Chen KS, Goutman SA, et al
   Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions.
   Ann Neurol. 2024;95:635-652.
   

   >> Share

   
   
5. ARVANITAKIS Z, Capuano AW, Tong H, Mehta RI, et al
   Associations of Serum Insulin and Related Measures With Neuropathology and Cognition in Older Persons With and Without Diabetes.
   Ann Neurol. 2024;95:665-676.
   

   >> Share

   
   

   
   BMC Geriatr

6. CHEN CY, Chiu CC, Huang CY, Cheng YC, et al
   Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain.
   BMC Geriatr. 2024;24:344.
   

   >> Share

   
   

   
   BMC Neurol

7. ALTY J, Goldberg LR, Roccati E, Lawler K, et al
   Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum.
   BMC Neurol. 2024;24:127.
   

   >> Share

   
   

   
   Br J Psychiatry

8. KINCHIN I, Walsh S, Dinh R, Kapuwa M, et al
   Dissonance in the face of Alzheimer's disease breakthroughs: clinician and lay stakeholder acceptance, concerns and willingness to pay for emerging disease-modifying therapies.
   Br J Psychiatry. 2024 Apr 17:1-7. doi: 10.1192/bjp.2024.
   

   >> Share

   
   

   
   Brain

9. LIMBERGER C, Zimmer ER
   Blood GFAP reflects astrocyte reactivity to Alzheimer's pathology in post-mortem brain tissue.
   Brain. 2024 Apr 18:awae104. doi: 10.1093.
   

   >> Share

   
   

   
   Brain Res

10. HAN L, Chen W, Li J, Zhao Y, et al
    Palmatine improves cognitive dysfunction in Alzheimer's disease model rats through autophagy pathway and regulation of gut microbiota.
    Brain Res. 2024;1835:148932.
    

    >> Share

    
    
11. UCHIUMI O, Zou J, Yamaki S, Hori Y, et al
    Disruption of sphingomyelin synthase 2 gene alleviates cognitive impairment in a mouse model of Alzheimer's disease.
    Brain Res. 2024;1835:148934.
    

    >> Share

    
    
12. LIU X, Chen J, Du Y, Tian Q, et al
    The changes of neurogenesis in the hippocampal dentate gyrus of SAMP8 mice and the effects of acupuncture and moxibustion.
    Brain Res. 2024;1831:148814.
    

    >> Share

    
    
13. CHEN Y, Li Y, Wu M, Li Z, et al
    Electroacupuncture improves cognitive function in APP/PS1 mice by inhibiting oxidative stress related hippocampal neuronal ferroptosis.
    Brain Res. 2024;1831:148744.
    

    >> Share

    
    

    
    Curr Alzheimer Res

14. SEN D, Rathee S, Pandey V, Jain SK, et al
    Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration.
    Curr Alzheimer Res. 2024 Apr 15. doi: 10.2174/0115672050309057240404075003.
    

    >> Share

    
    
15. KALYAANAMOORTHY S, Opare SK, Xu X, Ganesan A, et al
    Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.
    Curr Alzheimer Res. 2024 Apr 15. doi: 10.2174/0115672050301407240408033046.
    

    >> Share

    
    

    
    Int J Neurosci

16. BORIKAR SP, Sonawane DS, Tapre DN, Jain SP, et al
    Exploring the neuropharmacological potential of empagliflozin on nootropic and scopolamine-induced amnesic model of Alzheimer's like conditions in rats.
    Int J Neurosci. 2024 Apr 16:1-28. doi: 10.1080/00207454.2024.2342973.
    

    >> Share

    
    

    
    J Alzheimers Dis

17. CHANDRASEKARAN G, Xie SX
    Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231047.
    

    >> Share

    
    
18. ETEKOCHAY MO, Amaravadhi AR, Gonzalez GV, Atanasov AG, et al
    Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231135.
    

    >> Share

    
    
19. CHOI YY, Lee JJ, Te Nijenhuis J, Choi KY, et al
    Multi-Ethnic Norms for Volumes of Subcortical and Lobar Brain Structures Measured by Neuro I: Ethnicity May Improve the Diagnosis of Alzheimer's Disease1.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231182.
    

    >> Share

    
    
20. SIGHINOLFI G, Mitolo M, Pizzagalli F, Stanzani-Maserati M, et al
    Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231192.
    

    >> Share

    
    
21. CAI J, Xie D, Kong F, Zhai Z, et al
    Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231249.
    

    >> Share

    
    
22. TAHAMI MONFARED AA, Khachatryan A, Hummel N, Kopiec A, et al
    Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231259.
    

    >> Share

    
    
23. KHALED M, Al-Jamal H, Tajer L, El-Mir R, et al
    Alzheimer's Disease in Lebanon: Exploring Genetic and Environmental Risk Factors-A Comprehensive Review.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231432.
    

    >> Share

    
    
24. DAS S
    Omics Approaches in Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-240272.
    

    >> Share

    
    
25. 
    Erratum to: Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
    J Alzheimers Dis. 2024;98:1543-1546.
    

    >> Share

    
    
26. YOO HS, Kim HK, Lee JH, Chun JH, et al
    Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-230975.
    

    >> Share

    
    
27. DORADO-MARTINEZ C, Montiel-Flores E, Ordonez-Librado JL, Gutierrez-Valdez AL, et al
    Histological and Memory Alterations in an Innovative Alzheimer's Disease Animal Model by Vanadium Pentoxide Inhalation.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-230818.
    

    >> Share

    
    

    
    J Am Geriatr Soc

28. POPE TM, Brodoff L
    Medical aid in dying to avoid late-stage dementia.
    J Am Geriatr Soc. 2024;72:1216-1222.
    

    >> Share

    
    
29. HERNANDEZ-RUIZ V, Roubaud-Baudron C, Von Campe H, Retuerto N, et al
    Association between Helicobacter pylori infection and incident risk of dementia: The AMI cohort.
    J Am Geriatr Soc. 2024;72:1191-1198.
    

    >> Share

    
    
30. MUKHERJEE S, McDonald AD, Kesler SR, Cuevas H, et al
    Driving among individuals with chronic conditions: A systematic review of applied research using kinematic driving sensors.
    J Am Geriatr Soc. 2024;72:1242-1251.
    

    >> Share

    
    
31. MURAWSKI A, Ramirez-Zohfeld V, Mell J, Tschoe M, et al
    NegotiAge: Development and pilot testing of an artificial intelligence-based family caregiver negotiation program.
    J Am Geriatr Soc. 2024;72:1112-1121.
    

    >> Share

    
    

    
    J Neurochem

32. KWAN KH, Soreq H
    EDITOR SPOTLIGHT: Interview with Cholinergic Mechanisms Special Issue Guest Editor Hermona Soreq.
    J Neurochem. 2024;168:331-333.
    

    >> Share

    
    

    
    J Neurol

33. GUILOFF AE, Rudge P
    Amyloid antibody therapy for early-stage Alzheimer's disease: a critical review of three recent trials.
    J Neurol. 2024 Apr 13. doi: 10.1007/s00415-024-12361.
    

    >> Share

    
    

    
    JAMA

34. RUBIN R
    Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?
    JAMA. 2024 Apr 19. doi: 10.1001/jama.2024.1017.
    

    >> Share

    
    

    
    Lancet Neurol

35. WISCH JK, McKay NS, Boerwinkle AH, Kennedy J, et al
    Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.
    Lancet Neurol. 2024;23:500-510.
    

    >> Share

    
    
36. NORDBERG A
    Insights into the progression of genetic Alzheimer's disease from tau PET.
    Lancet Neurol. 2024;23:453-454.
    

    >> Share

    
    

    
    Nat Neurosci

37. RACHMIAN N, Medina S, Cherqui U, Akiva H, et al
    Identification of senescent, TREM2-expressing microglia in aging and Alzheimer's disease model mouse brain.
    Nat Neurosci. 2024 Apr 18. doi: 10.1038/s41593-024-01620.
    

    >> Share

    
    

    
    Nervenarzt

38. DODEL R, Berg D, Duning T, Kalbe E, et al
    [Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and diagnostics].
    Nervenarzt. 2024;95:353-361.
    

    >> Share

    
    
39. DODEL R, Berg D, Duning T, Kalbe E, et al
    [Dementia with Lewy bodies: old and new knowledge-Part 2: treatment].
    Nervenarzt. 2024;95:362-367.
    

    >> Share

    
    

    
    Neurobiol Aging

40. SHAFIEE N, Fonov V, Dadar M, Spreng RN, et al
    Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression.
    Neurobiol Aging. 2024;139:54-63.
    

    >> Share

    
    

    
    Neurology

41. GRASSET L, Bouteloup V, Cacciamani F, Pellegrin I, et al
    Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort.
    Neurology. 2024;102:e209307.
    

    >> Share

    
    

    
    Neurosci Lett

42. XIANG X, Xia S, Li S, Zeng Y, et al
    Study on the role and mechanism of Tan IIA in Alzheimer's disease based on CREB-BDNF-TrkB pathway.
    Neurosci Lett. 2024;830:137769.
    

    >> Share

    
    

    
    PLoS One

43. AWARAYI NS, Twum F, Hayfron-Acquah JB, Owusu-Agyemang K, et al
    A bilateral filtering-based image enhancement for Alzheimer disease classification using CNN.
    PLoS One. 2024;19:e0302358.
    

    >> Share

    
    
44. LEE C, Friedman A
    Generating PET scan patterns in Alzheimer's by a mathematical model.
    PLoS One. 2024;19:e0299637.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

45. SINGH PK, Simoes-Pires EN, Chen ZL, Torrente D, et al
    Lecanemab blocks the effects of the Abeta/fibrinogen complex on blood clots and synapse toxicity in organotypic culture.
    Proc Natl Acad Sci U S A. 2024;121:e2314450121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share